Member access

4-Traders Homepage  >  Shares  >  Nyse  >  AbbVie Inc    ABBV   US00287Y1091

ABBVIE INC (ABBV)

48
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
10/20/2014 10/21/2014 10/22/2014 10/23/2014 10/24/2014 Date
54.41(c) 56.29(c) 56.9(c) 59.52(c) 60.29(c) Last
17 954 637 17 522 116 16 048 709 14 729 311 10 360 961 Volume
+1.95% +3.46% +1.08% +4.60% +1.29% Change
More quotes
Company
AbbVie, Inc. is a research-based biopharmaceutical company.It engages in the discovery, development, manufacture and sale of a broad line of proprietary pharmaceutical products.The company's products are used to treat rheumatoid arthritis, psoriasis, Crohn's disease, HIV, cystic fibrosis... 
Sector
Pharmaceuticals
Calendar
01/30Earnings Release
Surperformance© rating of AbbVie Inc
Trading Rating : Investor Rating :
More about the company
Chart ABBVIE INC
Duration : Period :
AbbVie Inc Technical Analysis Chart | ABBV | US00287Y1091 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 19 675 M
EBIT 2014 6 823 M
Net income 2014 4 819 M
Debt 2014 4 722 M
Yield 2014 2,75%
Sales 2015 22 448 M
EBIT 2015 8 832 M
Net income 2015 6 672 M
Debt 2015 2 026 M
Yield 2015 3,22%
PER 2014 21,57
PER 2015 14,24
EV / Sales 2014 5,12x
EV / Sales 2015 4,37x
Capitalization 96 069 M
More Financials
Latest news on ABBVIE INC
2h ago ABBVIE : Shire finds prescription for growth as it posts record earnings
1d ago Chiquita turns to Brazilian group after Fyffes deal collapses
1d ago FTSE falls, posts strongest week since August
1d ago SHIRE : Ups Earnings Guidance A Third Time After Strong Third Quarter
1d ago Jilted Shire raises guidance again after third-quarter earnings jump
1d ago Pfizer's $11 billion buyback plan deflates AstraZeneca bid hopes
1d ago Pfizer's $11 billion buyback plan deflates AstraZeneca bid hopes
2d ago ABBVIE : Named a Top Employer in Science Magazine's Annual Survey for Second Con..
3d ago SHIRE : AbbVie Board Recommends Stockholders Vote Against Shire Transaction
3d ago ABBVIE : Announcement Of Notice To Shire Of AbbVie Board Intention To Reconsider..
3d ago ABBVIE : Announces New $5 Billion Stock Repurchase Program and Increases Dividen..
3d agoDJShire Files 8K - Termination Of Definitive Agreement
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF